BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 16206189)

  • 21. Molecular analysis of the t(1;19)(q23;p13) translocation observed in adult leukemias.
    Mitani K; Sasaki K; Ogawa S; Hayashi Y; Mano H; Yazaki Y; Hirai H
    Int J Hematol; 1994 Dec; 60(4):267-71. PubMed ID: 7894030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel TCF3-HLF fusion transcript in acute lymphoblastic leukemia with a t(17;19)(q22;p13).
    Panagopoulos I; Micci F; Thorsen J; Haugom L; Tierens A; Ulvmoen A; Heim S
    Cancer Genet; 2012 Dec; 205(12):669-72. PubMed ID: 23181981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cloning and functional characterization of MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins created by a variant t(1;19)(q23;p13.3) in acute lymphoblastic leukemia.
    Prima V; Gore L; Caires A; Boomer T; Yoshinari M; Imaizumi M; Varella-Garcia M; Hunger SP
    Leukemia; 2005 May; 19(5):806-13. PubMed ID: 15744350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1.
    Fu X; McGrath S; Pasillas M; Nakazawa S; Kamps MP
    Oncogene; 1999 Sep; 18(35):4920-9. PubMed ID: 10490826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The chimeric oncoproteins E2A-PBX1 and E2A-HLF are concentrated within spherical nuclear domains.
    LeBrun DP; Matthews BP; Feldman BJ; Cleary ML
    Oncogene; 1997 Oct; 15(17):2059-67. PubMed ID: 9366523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The highest affinity DNA element bound by Pbx complexes in t(1;19) leukemic cells fails to mediate cooperative DNA-binding or cooperative transactivation by E2a-Pbx1 and class I Hox proteins - evidence for selective targetting of E2a-Pbx1 to a subset of Pbx-recognition elements.
    Knoepfler PS; Kamps MP
    Oncogene; 1997 May; 14(21):2521-31. PubMed ID: 9191052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical validation of a monochrome real-time multiplex assay for translocations in childhood acute lymphoblastic leukemia.
    Siraj AK; Ozbek U; Sazawal S; Sirma S; Timson G; Al-Nasser A; Bhargava M; El Solh H; Bhatia K; Gutiérrez MI
    Clin Cancer Res; 2002 Dec; 8(12):3832-40. PubMed ID: 12473597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fusion with E2A alters the transcriptional properties of the homeodomain protein PBX1 in t(1;19) leukemias.
    LeBrun DP; Cleary ML
    Oncogene; 1994 Jun; 9(6):1641-7. PubMed ID: 8183558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Severe hypercalcemia complicated in acute lymphoblastic leukemia (ALL) with E2A-HLF fusion gene: report of two cases and literature review].
    Yang J; Zhou X; Wang B; Gao C; Zhang RD; Li B
    Zhonghua Xue Ye Xue Za Zhi; 2009 Sep; 30(9):615-8. PubMed ID: 19954622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia.
    Hunger SP; Ohyashiki K; Toyama K; Cleary ML
    Genes Dev; 1992 Sep; 6(9):1608-20. PubMed ID: 1516826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New E2A/PBX1 fusion transcript in a patient with t(1;19)(q23;p13) acute lymphoblastic leukemia.
    Numata S; Kato K; Horibe K
    Leukemia; 1993 Sep; 7(9):1441-4. PubMed ID: 8103813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two types of genomic rearrangements create alternative E2A-HLF fusion proteins in t(17;19)-ALL.
    Hunger SP; Devaraj PE; Foroni L; Secker-Walker LM; Cleary ML
    Blood; 1994 May; 83(10):2970-7. PubMed ID: 8180393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1.
    Calvo KR; Knoepfler P; McGrath S; Kamps MP
    Oncogene; 1999 Dec; 18(56):8033-43. PubMed ID: 10637514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The gene encoding the granulocyte colony-stimulating factor receptor is a target for deregulation in pre-B ALL by the t(1;19)-specific oncoprotein E2A-Pbx1.
    de Lau WB; Hurenkamp J; Berendes P; Touw IP; Clevers HC; van Dijk MA
    Oncogene; 1998 Jul; 17(4):503-10. PubMed ID: 9696044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chimaeric oncoproteins resulting from chromosomal translocations in acute lymphoblastic leukaemia.
    Hunger SP; Cleary ML
    Semin Cancer Biol; 1993 Dec; 4(6):387-99. PubMed ID: 8142624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of the DBP promoter by PAR proteins and in leukemic cells bearing an E2A/HLF translocation.
    Newcombe K; Glassco T; Mueller C
    Biochem Biophys Res Commun; 1998 Apr; 245(2):633-9. PubMed ID: 9571207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoter analysis of TFPT (FB1), a molecular partner of TCF3 (E2A) in childhood acute lymphoblastic leukemia.
    Brambillasca F; Mosna G; Ballabio E; Biondi A; Boulukos KE; Privitera E
    Biochem Biophys Res Commun; 2001 Nov; 288(5):1250-7. PubMed ID: 11700047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19.
    Inukai T; Hirose K; Inaba T; Kurosawa H; Hama A; Inada H; Chin M; Nagatoshi Y; Ohtsuka Y; Oda M; Goto H; Endo M; Morimoto A; Imaizumi M; Kawamura N; Miyajima Y; Ohtake M; Miyaji R; Saito M; Tawa A; Yanai F; Goi K; Nakazawa S; Sugita K
    Leukemia; 2007 Feb; 21(2):288-96. PubMed ID: 17183364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patients.
    van der Holt B; Van den Heuvel-Eibrink MM; Van Schaik RH; van der Heiden IP; Wiemer EA; Vossebeld PJ; Löwenberg B; Sonneveld P
    Clin Pharmacol Ther; 2006 Nov; 80(5):427-39. PubMed ID: 17112800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of annexin II by cytokine-initiated signaling pathways and E2A-HLF oncoprotein.
    Matsunaga T; Inaba T; Matsui H; Okuya M; Miyajima A; Inukai T; Funabiki T; Endo M; Look AT; Kurosawa H
    Blood; 2004 Apr; 103(8):3185-91. PubMed ID: 15070701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.